Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  You, Jing ^a,b   Sriplung, Hutcha ^a   Geater, Alan ^a   Chongsuvivatwong, Virasakdi ^a   Zhuang, Lin ^c   Li, Yun Li ^c   Lei, Hua ^c   Liu, Jun ^c   Chen, Hong Ying ^b   Tang, Bao Zhang ^b   Huang, Jun Hua ^d  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c Third Municipal People's Hospital of Kunming   (China)

^d Yunnan General Hospital of the Chinese People's Armed Police Forces   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; ANTIVIRUS AGENT; DRUG DERIVATIVE; GUANINE; HEPATITIS B(E) ANTIGEN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE SIZE; SEROCONVERSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TREATMENT DURATION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; BIOLOGICAL MODEL; BLOOD; COHORT ANALYSIS; DRUG EFFECT; HEPATITIS B VIRUS; IMMUNOLOGY; LIVER FUNCTION TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSIOLOGY; REGRESSION ANALYSIS; VIROLOGY;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DNA, VIRAL; FEMALE; GUANINE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; T-LYMPHOCYTE SUBSETS; VIRAL LOAD; VIREMIA; VIRUS REPLICATION;

EID: 54949146451     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-123     Document Type: Article

References (31)

1. World Health Organization Department of Communicable diseases surveillance and response. Hepatitis B WHO Fact Sheets http://www.who.int Accessed: September 24, 2004
2. Stoop JN Molen van der RG Kuipers EJ Kusters JG Janssen HL Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B Virology 2007, 361:141-148. 10.1016/j.virol.2006.11.018 17184802
3. Michalak TI Hodgson PD Churchill ND Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection J Virol 2000, 74:4483-4494. 111969 10775584 10.1128/JVI.74.10.4483-4494.2000
4. Tulek N Saglam SK Saglam M Turkyilmaz R Yildiz M Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection Hepatogastroenterology 2000, 47:828-831. 10919040
5. Khettry U Anand N Gordon FD Jenkins RL Tahan SR Loda M Lewis WD Recurrent hepatitis B, hepatitis C, and combined hepatitis B and C in liver allografts: A comparative pathological study Hum Pathol 2000, 31:101-108. 10.1016/S0046-8177(00)80205-1 10665920
6. Baumert TF Thimme R von Weizsäcker F Pathogenesis of hepatitis B virus infection World J Gastroenterol 2007, 13:82-90. 17206757
7. Bertoletti A Gehring AJ The immune response during hepatitis B virus infection J Gen Virol 2006, 87:1439-1449. 10.1099/vir.0.81920-0 16690908
8. Liu DX A new hypothesis of pathogenetic mechanism of viral hepatitis B and C Med Hypotheses 2001, 56:405-408. 10.1054/mehy.2000.1157 11359371
9. Stoop JN Molen van der RG Baan CC Laan van der LJ Kuipers EJ Kusters JG Janssen HL Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection Hepatology 2005, 41:771-778. 10.1002/hep.20649 15791617
10. Franzese O Kennedy PT Gehring AJ Gotto J Williams R Maini MK Bertoletti A Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection J Virol 2005, 79:3322-3328. 1075696 15731226 10.1128/JVI.79.6.3322-3328.2005
11. Boni C Bertoletti A Penna A Cavalli A Pilli M Urbani S Scognamiglio P Boehme R Panebianco R Fiaccadori F Ferrari C Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B J Clin Invest 1998, 102:968-975. 508962 9727065 10.1172/JCI3731
12. Boni C Penna A Ogg GS Bertoletti A Pilli M Cavallo C Cavalli A Urbani S Boehme R Panebianco R Fiaccadori F Ferrari C Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy Hepatology 2001, 33:963-971. 10.1053/ jhep.2001.23045 11283861
13. Boni C Penna A Bertoletti A Lamonaca V Rapti I Missale G Pilli M Urbani S Cavalli A Cerioni S Panebianco R Jenkins J Ferrari C Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B J Hepatol 2003, 39:595-605. 10.1016/ S0168-8278(03)00292-7 12971971
14. Dienstag JL Wei LJ Xu D Kreter B Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients Clin Drug Investig 2007, 27:35-49. 10.2165/ 00044011-200727010-00003 17177578
15. Tillmann HL Antiviral therapy and resistance with hepatitis B virus infection World J Gastroenterol 2007, 13:125-140. 17206760
16. Rivkin A A review of entecavir in the treatment of chronic hepatitis B infection Curr Med Res Opin 2005, 21:1845-56. 10.1185/030079905X65268 16307706
17. Gish RG Perrillo RP Jacobson IM Customizing the management of chronic hepatitis B virus infection Semin Liver Dis 2007, 27:9-17. 10.1055/ s-2007-984695 17701845
18. Keeffe EB Marcellin P New and emerging treatment of chronic hepatitis B Clin Gastroenterol Hepatol 2007, 5:285-294. 10.1016/j.cgh.2006.09.036 17218162
19. Chang TT Gish R de Man R Gadano A Sollano J Chao YC Lok AS Han KH Goodman Z Zhu J Apelian D A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B N Engl J Med 2006, 354:1001-1010. 10.1056/NEJMoa051285 16525137
20. Lai CL Shouval D Lok AS Chang TT Cheinquer H Goodman Z DeHertogh D Wilber R Zinki RC Cross A Colonno R Fernandes L Entecavir versus lamivudine for HBeAg-negative chronic hepatitis B N Engl J Med 2006, 354:1011-1020. 10.1056/NEJMoa051287 16525138
21. Yao G Chen CJ Lu W Ren H Tan D Wang Y Xu D Jiang M Liu J Xu D MacDonald L Entecavir is superior to lamivudine for the treatment of chronic hepatitis B (CHB): Results of a phase 3 Chinese study (ETV-023) in nucleoside-naïve patients J Hepatol 2006, 44:S193.
22. Sherman M Yurdaydin C Sollano J Silva M Liaw YF Cianciara J Boron-Kaczmarska A Martin P Goodman Z Colonno R Cross A Denisky G Kreter G Hindes R AI463026 BEHoLD Study Group Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B Gasgtroenterol 2006, 130:2039-2049. 10.1053/j.gastro.2006.04.007
23. Lok AS McMahon BJ Chronic hepatitis B Hepatology 2007, 45:507-539. 10.1002/hep.21513 17256718
24. R Development Core Team R: A language and environment for statistical computing R Foundation for Statistical Computing, Vienna, Austria http://www.R-project.org ISBN 3-900051-07-0, Assessed: October 3, 2007
25. Chongsuvivatwong V The epicalc package http://www.cran.R-project.org Assessed: November 1, 2007.
26. Leung N Peng C-Y Sollano J Lesmana L Yuen M-F Jeffers L Han H-W Sherman M Zhu J Mencarini K Colonno R Cross A Wilber R Lopez-Talavera J-C Entecavir results in higher HBV DNA reduction vs adefovir in chronically infected HBeAg(+) antiviral-naïve adults: 24 wk results (E.A.R.L.Y. study) Hepatology 2006, 44:554A.
27. Gish RG Lok AS Chang TT De Man RA Gadano A Sollano J Han KH Chao YC Lee SD Harris JY Colonno R Brett-Smith H Entecavir Therapy for up to 96 Weeks in Patients With HBeAg-Positive Chronic Hepatitis B Gastroenterology 2007, 133:1437-1444. 10.1053/j.gastro.2007.08.025 17983800
28. Stoop JN Molen van der RG Kuipers EJ Kusters JG Janssen HL Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B Virology 2007, 361:141-148. 10.1016/j.virol.2006.11.018 17184802
29. Lau GK Cooksley H Ribeiro RM Powers KA Shudo E Bowden S Hui CK Anderson J Sorbel J Mondou E Rousseau F Lewin S Perelson AS Locornini S Naoumov NV Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B Antivir Ther 2007, 12:705-718. 17713154
30. Kondo Y Asabe S Kobayashi K Shiina M Niitsuma H Ueno Y Kobayashi T Shimosegawa T Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity J Med Virol 2004, 74:425-433. 10.1002/jmv.20194 15368520
31. Mizukoshi E Sidney J Livingston B Ghany M Hoofnagle JH Sette A Rehermann B Cellular immune responses to the hepatitis B virus polymerase J Immunol 2004, 173:5863-5871. 15494540